Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 3
2013 2
2014 3
2015 1
2016 1
2017 3
2018 1
2019 2
2020 3
2021 5
2022 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
RoB 2: a revised tool for assessing risk of bias in randomised trials.
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. Sterne JAC, et al. Among authors: junqueira dr. BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898. BMJ. 2019. PMID: 31462531 Free article. No abstract available.
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials.
Junqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S; CONSORT Harms Group. Junqueira DR, et al. BMJ. 2023 Apr 24;381:e073725. doi: 10.1136/bmj-2022-073725. BMJ. 2023. PMID: 37094878 Free article. Clinical Trial. No abstract available.
Preeclampsia and ABO blood groups: a systematic review and meta-analysis.
Alpoim PN, de Barros Pinheiro M, Junqueira DR, Freitas LG, das Graças Carvalho M, Fernandes AP, Komatsuzaki F, Gomes KB, Sant'Ana Dusse LM. Alpoim PN, et al. Mol Biol Rep. 2013 Mar;40(3):2253-61. doi: 10.1007/s11033-012-2288-2. Epub 2012 Nov 27. Mol Biol Rep. 2013. PMID: 23184045 Review.
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials.
Junqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S; CONSORT Harms Group. Junqueira DR, et al. J Clin Epidemiol. 2023 Jun;158:149-165. doi: 10.1016/j.jclinepi.2023.04.005. Epub 2023 Apr 24. J Clin Epidemiol. 2023. PMID: 37100738 Free article.
Pentasaccharides for the treatment of deep vein thrombosis.
Brandao GM, Junqueira DR, Rollo HA, Sobreira ML. Brandao GM, et al. Among authors: junqueira dr. Cochrane Database Syst Rev. 2017 Dec 2;12(12):CD011782. doi: 10.1002/14651858.CD011782.pub2. Cochrane Database Syst Rev. 2017. PMID: 29199766 Free PMC article. Review.
29 results